Problem 4 - Brenner and Stevens’ Pharmacology

Question

Mutations to the kat \(\mathrm{G}\) gene may confer resistance to which agent? (A) isoniazid (B) pyrazinamide (C) amikacin (D) rifampin (E) ethambutol

Step-by-Step Solution

Answer

Mutations to the kat G gene may confer resistance to isoniazid (A).

Step 1: Understand the Function of the kat G Gene

The kat G gene encodes the enzyme catalase-peroxidase. This enzyme is important for the activation of certain drugs that are used to treat bacterial infections, specifically Mycobacterium tuberculosis.

Step 2: Determine Which Drug is Activated by the Enzyme

Isoniazid is a prodrug that requires activation by the catalase-peroxidase enzyme product of kat G gene in order to exert its antibacterial effects. Therefore, mutations in this gene could prevent isoniazid from being activated, leading to resistance.

Step 3: Evaluate the Options

Given the function of kat G and knowledge of anti-tuberculosis drugs, among the provided options, isoniazid resistance is specifically associated with mutations in the kat G gene. Other drugs listed do not primarily rely on the kat G gene's enzyme for activation or function.

Key Concepts

Drug Resistance

Drug resistance is a phenomenon where a microorganism, such as a bacterium, becomes insensitive to a drug that was initially effective in treating infections caused by it.
Antibiotic resistance occurs when bacteria undergo mutations or acquire resistance genes, which allow them to survive even in the presence of antibiotics.

• It makes standard treatments ineffective.
• Affected infections persist, possibly spreading to others.
• Increasing drug resistance demands alternative treatments or higher doses.

Understanding drug resistance is crucial in preventing and controlling infectious diseases.
This concept is particularly important in the treatment of tuberculosis, a severe infectious disease that largely targets the lungs. Mechanisms of drug resistance include:

• Genetic mutations within the bacteria that affect the drug target.
• Efflux pumps that bacteria use to expel the drug.
• Enzymes that modify or destroy the drug.

kat G Gene

The kat G gene plays a pivotal role in bacterial physiology, particularly in Mycobacterium tuberculosis.
This gene encodes the enzyme catalase-peroxidase.
The enzyme has multiple functions, including protecting the bacterium from oxidative damage. However, its most crucial role in the context of pharmacology education is its involvement in drug activation.

• The enzyme catalase-peroxidase is essential for converting certain drugs into their active forms.
• This activation is vital for the drugs to exert their intended effects on bacterial cells.
• Mutations in the kat G gene can lead to a dysfunctional enzyme.

When these mutations occur, drugs that depend on this enzyme for activation may become ineffective, leading to drug resistance.
Understanding the function and importance of the kat G gene is critical in choosing effective treatments for infections caused by Mycobacterium tuberculosis.

Isoniazid Activation

Isoniazid is a well-known prodrug utilized in the treatment of tuberculosis.
As a prodrug, it requires biochemical transformation within the body to become active.
The kat G gene's enzyme, catalase-peroxidase, plays a crucial role in this activation process. The mechanism involves:

• Peroxide-mediated oxidative activation of isoniazid by the catalase-peroxidase enzyme.
• The resulting active form inhibits the synthesis of mycolic acids, essential components of the bacterial cell wall.
• This bactericidal action effectively kills Mycobacterium tuberculosis cells.

Any mutations in the kat G gene impact the enzyme's ability to activate isoniazid.
Thus, altering the efficacy of this drug can lead to resistance. This makes monitoring genetic mutations in tuberculosis patients crucial to ensure proper treatment.

Antituberculosis Drugs

Antituberculosis drugs are a group of medications designed to combat infections caused by Mycobacterium tuberculosis.
They are vital in the treatment and control of tuberculosis, which remains a leading cause of infectious disease mortality worldwide. The standard regimen often includes:

• Isoniazid
• Rifampin
• Pyrazinamide
• Ethambutol
• Amikacin (in some cases)

Each of these drugs works through different mechanisms to eliminate the tuberculosis bacteria.
For instance,

• Isoniazid targets the synthesis of the bacterial cell wall.
• Rifampin inhibits RNA synthesis.
• Pyrazinamide acts under acidic conditions inside the macrophages.

The effective use of these drugs in combination is key to preventing drug resistance and achieving successful treatment outcomes.
Mutations to genes like kat G can impact the efficacy of these drugs, notably isoniazid, and highlight the need for continuous monitoring and personalized treatment approaches.